Release Date: 22/12/22 16:54 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 613.22KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%